Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention

Cannabis and Cannabinoid Research
Eugene L Scharf

Abstract

Introduction: The endocannabinoid system (ECS) regulates functions throughout human physiology, including neuropsychiatric, cardiovascular, autonomic, metabolic, and inflammatory states. The complex cellular interactions regulated by the ECS suggest a potential for vascular disease and stroke prevention by augmenting central nervous and immune cell endocannabinoid signaling. Discussion: The endocannabinoid N-arachidonoylethanolamine (anandamide) plays a central role in augmenting these processes in cerebrovascular and neurometabolic disease. Furthermore, cannabidiol (CBD), a nonpsychoactive constituent of Cannabis, is an immediate therapeutic candidate both for potentiating endocannabinoid signaling and for acting at multiple pharmacological targets. Conclusion: This speculative synthesis explores the current state of knowledge of the ECS and suggests CBD as a therapeutic candidate for stroke prevention by exerting favorable augmentation of the homeostatic effects of the ECS and, in turn, improving the metabolic syndrome, while simultaneously stalling the development of atherosclerosis.

References

Nov 13, 2001·British Journal of Pharmacology·N Jamshidi, D A Taylor
Mar 12, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·D CotaU Pagotto
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nazik RaymanRuud Delwel
Mar 8, 2005·Journal of Biochemistry·Seishi KishimotoTakayuki Sugiura
Mar 1, 2006·Molecular Immunology·Sharmistha GhoshRamesh K Ganju
Mar 17, 2009·European Journal of Pharmacology·Saoirse E O'SullivanDavid A Kendall
May 12, 2009·Progress in Neurobiology·Jonathan SavitzWayne C Drevets
Aug 26, 2009·Communicative & Integrative Biology·Jürg Gertsch
Dec 24, 2010·British Journal of Pharmacology·Luciano De PetrocellisVincenzo Di Marzo
Jan 18, 2011·Pharmacology, Biochemistry, and Behavior·América A ScopinhoLeonardo B M Resstel
Feb 10, 2011·European Heart Journal·Alessandra QuercioliThomas H Schindler
Dec 2, 2011·Current Drug Safety·Mateus Machado BergamaschiJosé Alexandre S Crippa
Mar 1, 2012·Lipids in Health and Disease·W S Vanessa HoCecilia J Hillard
Mar 21, 2012·Orvosi hetilap·Dénes Kleiner, Kálmán Ditrói
Oct 4, 2012·Journal of Hypertension·Stefan EngeliJens Jordan
Apr 12, 2014·The International Journal of Biochemistry & Cell Biology·Valeria GasperiMauro Maccarrone
Feb 11, 2015·The Journal of Biological Chemistry·Matthew W ElmesDale G Deutsch
Jul 29, 2015·British Journal of Pharmacology·R B LaprairieE M Denovan-Wright
Aug 13, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Clementino Ibeas BihBenjamin J Whalley
May 26, 2017·The New England Journal of Medicine·Orrin DevinskyUNKNOWN Cannabidiol in Dravet Syndrome Study Group

❮ Previous
Next ❯

Citations

Mar 4, 2020·Biomolecules·Iwona Jarocka-KarpowiczElżbieta Skrzydlewska
May 27, 2020·BMC Health Services Research·Steinunn A OlafsdottirThora B Hafsteinsdottir
Dec 29, 2019·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Andreas Falck LahelleBritt Normann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2022 Meta ULC. All rights reserved